These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3456226)

  • 1. A hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 5-hydroxymethylchrysene.
    Okuda H; Hiratsuka A; Nojima H; Watabe T
    Biochem Pharmacol; 1986 Feb; 35(3):535-8. PubMed ID: 3456226
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the carcinogen, 5-hydroxymethylchrysene, to the mutagenic sulphate ester by mouse skin sulphotransferase.
    Okuda H; Nojima H; Watanabe N; Miwa K; Watabe T
    Biochem Pharmacol; 1988 Mar; 37(5):970-3. PubMed ID: 2964238
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivation of the carcinogen, 5-hydroxymethylchrysene, by glutathione conjugation via a sulphate ester in hepatic cytosol.
    Okuda H; Miwa K; Nojima H; Watabe T
    Biochem Pharmacol; 1986 Dec; 35(24):4573-6. PubMed ID: 3790172
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulphotransferase-mediated activation of the carcinogen 5-hydroxymethyl-chrysene. Species and sex differences in tissue distribution of the enzyme activity and a possible participation of hydroxysteroid sulphotransferases.
    Okuda H; Nojima H; Watanabe N; Watabe T
    Biochem Pharmacol; 1989 Sep; 38(18):3003-9. PubMed ID: 2783155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 7-hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 7-hydroxymethylbenz[a]anthracene.
    Watabe T; Hakamata Y; Hiratsuka A; Ogura K
    Carcinogenesis; 1986 Feb; 7(2):207-14. PubMed ID: 3948310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene.
    Amin S; Juchatz A; Furuya K; Hecht SS
    Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in drug conjugation and their consequences for drug toxicity. Sulfation, glucuronidation and glutathione conjugation.
    Mulder GJ
    Chem Biol Interact; 1986 Jan; 57(1):1-15. PubMed ID: 3081267
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfate conjugation of neurotransmitters and drugs. Introduction.
    Weinshilboum RM
    Fed Proc; 1986 Jul; 45(8):2220-2. PubMed ID: 2873063
    [No Abstract]   [Full Text] [Related]  

  • 9. Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes.
    Ogura K; Sohtome T; Sugiyama A; Okuda H; Hiratsuka A; Watabe T
    Mol Pharmacol; 1990 Jun; 37(6):848-54. PubMed ID: 2113604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of sulphate transfer from 4-nitrophenylsulphate to phenolic acceptors via liver cytosolic sulphotransferase.
    Anhalt E; Holloway CJ; Brunner G; Trautschold I
    Enzyme; 1982; 27(3):171-8. PubMed ID: 6951713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the carcinogen [3H]6-nitrochrysene in the preweanling mouse: identification of 6-aminochrysene-1,2-dihydrodiol as the probable proximate carcinogenic metabolite.
    Delclos KB; el-Bayoumy K; Hecht SS; Walker RP; Kadlubar FF
    Carcinogenesis; 1988 Oct; 9(10):1875-84. PubMed ID: 3168165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of C8-modified deoxyinosine and N2- and C8-modified deoxyguanosine as major products of the in vitro reaction of N-hydroxy-6-aminochrysene with DNA and the formation of these adducts in isolated rat hepatocytes treated with 6-nitrochrysene and 6-aminochrysene.
    Delclos KB; Miller DW; Lay JO; Casciano DA; Walker RP; Fu PP; Kadlubar FF
    Carcinogenesis; 1987 Nov; 8(11):1703-9. PubMed ID: 3664962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hymenolepis diminuta: lack of sulphate activation and sulphotransferase activity.
    Raines PS; Barrett J
    Exp Parasitol; 1988 Apr; 65(2):209-13. PubMed ID: 3162420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic metabolites of 5-methylchrysene.
    Pataki J; Lee H; Harvey RG
    Carcinogenesis; 1983; 4(4):399-402. PubMed ID: 6839413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphate conjugation of biologically active monoamines and their metabolites by human platelet phenolsulphotransferase.
    Rein G; Glover V; Sandler M
    Clin Chim Acta; 1981 Apr; 111(2-3):247-56. PubMed ID: 6939513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative metabolism and DNA binding of 6-nitro-5-methylchrysene and 5-methylchrysene.
    Shiue GH; el-Bayoumy K; Hecht SS
    Carcinogenesis; 1987 Sep; 8(9):1327-31. PubMed ID: 3621469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver.
    Miller EC; Miller JA; Boberg EW; Delclos KB; Lai CC; Fennell TR; Wiseman RW; Liem A
    Carcinog Compr Surv; 1985; 10():93-107. PubMed ID: 3904999
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenolsulphotransferase.
    van Kempen GM; Pennings EJ
    Lancet; 1982 May; 1(8281):1121. PubMed ID: 6122910
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzymatic sulfation of bile salts. II. Studies on bile salt sulfotranferase from rat kidney.
    Chen LJ; Imperato TJ; Bolt RJ
    Biochim Biophys Acta; 1978 Feb; 522(2):443-51. PubMed ID: 23845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.